Ohio confirms first two human West Nile virus cases of 2015

The state of Ohio recently confirmed that it has had its first two human cases of West Nile virus for the year 2015. Read More »

Novavax unveils positive results for seasonal flu vaccine

Novavax Inc., a clinical-stage vaccine company that specializes in the discovery, creation and sales of recombinant nanoparticle vaccines and adjuvants, recently announced the positive results from its phase two trial of the company’s quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate. Read More »

Advancements made with vaccines for middle ear infections

A team of scientists from the Griffith University’s Institute for Glycomics and the Nationwide Children’s Hospital based in Ohio recently discovered new evidence that will help vaccine developers create vaccines for middle ear infections. Read More »

Pennsylvania reports year's 1st West Nile case

Venango County woman recently released from hospital with possible mosquito-borne virus Read More »

Ebola vaccine trial shows promising results

The results of an interim analysis of VSV-EBOV (Merck, Sharp & Dohme) Guinea Phase II efficacy trial show promise as it is highly effective against the Ebola virus. Read More »

Computer model successfully predicts flu outbreaks in subtropical climates

A team of scientists, from Columbia University’s Mailman School of Public Health and the University of Hong Kong’s School of Public Health of Li Ka Shing Faculty of Medicine, recently demonstrated a computer model that can predict influenza outbreaks within subtropical climates. Read More »

Study on the development of T follicular helper cells

A team of scientists from the La Jolla Institute for Allergy and Immunology recently identified a set of master regulators that control the development of T follicular helper cells, also called T cells or TFH cells. Read More »

Minnesota shows improved adolescent vaccination rates

New data from the Centers for Disease Control and Prevention (CDC) shows that Minnesota has had increased adolescent vaccination rates for 2014. Read More »

Study finds HVTN 505 vaccine recognizes, won't neutralize HIV

A team of scientists from the National Institute of Allergy and Infectious Diseases and Duke University recently conducted a study to explain why the HVTN 505 trial’s candidate vaccine did not protect subjects against HIV infections. Read More »

Analysis offers insights on how to execute National HIV-AIDS strategy

The Foundation for AIDS Research (amfAR), in a partnership with the National HIV/AIDS Initiative at the O’Neill Institute for National and Global Law at Georgetown Law School, released a report on Thursday recommending how individual U.S. states can help the nation execute the National HIV/AIDS Strategy. Read More »